Clinical Trials Browser

Has results × Breast Neoplasms × Sirolimus × Clear all

NCT02642094 2023-12-05

Aging Mammary Stem Cells and Breast Cancer Prevention

Phase 2 Terminated

58 enrolled 11 charts

Breast Neoplasms

NCT00376688 2020-02-24

Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

31 enrolled 5 charts

Breast Neoplasms

NCT00699491 2018-06-13

Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 1/2 Completed

48 enrolled 14 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01797120 2018-05-30

PrE0102

Phase 2 Completed

131 enrolled 12 charts

Breast Neoplasms

NCT01390818 2017-03-07

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

146 enrolled 42 charts

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT00411788 2016-09-21

A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer

Phase 2 Completed

11 enrolled 8 charts

Breast Neoplasms